rapcabtagene autoleucel clinical trials
4 indexed studies · 3 currently recruiting
- RecruitingPHASE2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
This study is testing a new cell therapy called rapcabtagene autoleucel for severe lupus (SLE) or lupus affecting the kidneys (lupus nephritis). It aims to see how well it works and if it's safe for people whose current treatments aren't effective.
For: Lupus Erythematosus, Systemic · Lupus NephritisUnited States · Australia · Austria - Active not recruitingPHASE2
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
This study is testing a new cell therapy called rapcabtagene autoleucel for severe inflammatory muscle diseases (myositis). It aims to see if it's safe and helps people whose current treatments aren't working well.
For: Idiopathic Inflammatory MyopathiesUnited States · Australia · Brazil - RecruitingPHASE2
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
This study is testing a new treatment, rapcabtagene autoleucel, against an existing one, rituximab, for severe diffuse scleroderma. We want to see if the new treatment is safe and effective in helping people with this condition and improving their symptoms.
For: Scleroderma, DiffuseUnited States · Argentina · Australia - RecruitingPHASE2
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
This study looks at a new treatment called rapcabtagene autoleucel for severe forms of a condition called ANCA-Associated Vasculitis (AAV), specifically GPA and MPA. It aims to see how well it works and if it's safe compared to current treatments.
For: ANCA Associated Vasculitis (AAV)United States · Brazil · Israel